1. Home
  2. RGLS vs BOTJ Comparison

RGLS vs BOTJ Comparison

Compare RGLS & BOTJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGLS
  • BOTJ
  • Stock Information
  • Founded
  • RGLS 2007
  • BOTJ 1998
  • Country
  • RGLS United States
  • BOTJ United States
  • Employees
  • RGLS N/A
  • BOTJ N/A
  • Industry
  • RGLS Biotechnology: Pharmaceutical Preparations
  • BOTJ Major Banks
  • Sector
  • RGLS Health Care
  • BOTJ Finance
  • Exchange
  • RGLS Nasdaq
  • BOTJ Nasdaq
  • Market Cap
  • RGLS 74.0M
  • BOTJ 63.2M
  • IPO Year
  • RGLS 2012
  • BOTJ N/A
  • Fundamental
  • Price
  • RGLS $1.31
  • BOTJ $13.09
  • Analyst Decision
  • RGLS Strong Buy
  • BOTJ
  • Analyst Count
  • RGLS 6
  • BOTJ 0
  • Target Price
  • RGLS $10.33
  • BOTJ N/A
  • AVG Volume (30 Days)
  • RGLS 820.1K
  • BOTJ 5.5K
  • Earning Date
  • RGLS 03-20-2025
  • BOTJ 01-31-2025
  • Dividend Yield
  • RGLS N/A
  • BOTJ 3.06%
  • EPS Growth
  • RGLS N/A
  • BOTJ N/A
  • EPS
  • RGLS N/A
  • BOTJ 1.75
  • Revenue
  • RGLS N/A
  • BOTJ $45,028,000.00
  • Revenue This Year
  • RGLS N/A
  • BOTJ N/A
  • Revenue Next Year
  • RGLS N/A
  • BOTJ N/A
  • P/E Ratio
  • RGLS N/A
  • BOTJ $7.49
  • Revenue Growth
  • RGLS N/A
  • BOTJ 5.24
  • 52 Week Low
  • RGLS $0.83
  • BOTJ $9.65
  • 52 Week High
  • RGLS $3.79
  • BOTJ $17.05
  • Technical
  • Relative Strength Index (RSI)
  • RGLS 53.78
  • BOTJ 41.59
  • Support Level
  • RGLS $1.22
  • BOTJ $12.80
  • Resistance Level
  • RGLS $1.60
  • BOTJ $13.85
  • Average True Range (ATR)
  • RGLS 0.13
  • BOTJ 0.40
  • MACD
  • RGLS 0.03
  • BOTJ -0.00
  • Stochastic Oscillator
  • RGLS 50.85
  • BOTJ 26.98

About RGLS Regulus Therapeutics Inc.

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

About BOTJ Bank of the James Financial Group Inc.

Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments, community banking; mortgage banking, and investment advisory services.

Share on Social Networks: